Virtual Practice
Recommend

Dr. Sewa Legha

Internal Medicine - Oncology
Houston, TX
About
Insights
Network
Checklists
Welcome!
About me
I specialize in
Internal Medicine - Oncology
I have been in practice
48 years
I speak
Hindi
I'm known for
Doctor
Votes
Member
Votes
Breast cancer
13th
Nationally
125
Oncology
3rd
Nationally
18
Malignant melanoma
1st
Nationally
3
Recommend me
My answers and insights have
Saved 86 lives
Helped 12,496,066 people
Received 10,970 doctor agrees
Received 7,349 thanks
Here are kind words from others
I highly endorse Dr. Legha as an expert on HealthTap and HealthTap Prime. His comments and insights provide valuable guidance and information
Your dedication and commitment to providing quality health consultation on HealthTap is greatly admired and a true benefit to your patients.
I endorse Dr. Legha. Dr Legha clearly has a vast knowledge of Medical oncology & is willing to share it as a public service via Healthtap.
Dr Legha's posts are always thought provoking. One can truly see the commitment and passion to medicine. Keep the great answers coming.
Dr Legha, provides many knowledgeable and helpful answers. He is an asset to healthtap.
I Highly recommend Dr Lega for his great biography, publications & awards
Recommend me
I am located at
Sewa S. Legha, MD, Medical Oncology
8501 Hawaii Lane
Houston , TX 77040

I was educated and trained at
Medical / Graduate School
Punjab University, Christian Medical College, Ludhiana, India
1971
Fellowships
Medical Oncology MD Anderson cancer center, Houston
I've won the following awards
TOP ONCOLOGIST, The Nation
2018
Top Oncologist, the Nation
Fall 2017
Top Oncologist, the Nation
Spring 2017
I've published
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
Melanoma Res., Feb;19(1):42-9 (2009)
Dr. Victor Prieto
Phase II study of thalidomide in patients with metastatic melanoma.
Melanoma Res., Feb;14(1):57-62 (2004)
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma.
Cancer., Jul;95(1):127-34 (2002)
Here are some of my top insights